Ironwood Pharmaceuticals | IRWD - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Akebia Therapeutics USD 8.39M 12.8M 2026-03
Almirall EUR 235.53M 22.52M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amarin USD 18.8M 29.36M 2026-06
Ardelyx USD 28.2M 8.96M 2026-03
Astellas Pharma JPY 199.75B 17.8B 2026-03
AstraZeneca USD 22.89B 388M 2026-06
Charles River Laboratories USD 133.95M 14.85M 2026-03
Coherus Biosciences USD 9.91M 14.98M 2025-12
Emergent BioSolutions USD 112.2M 500K 2023-12
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
Incyte USD 1.39B 1.16B 2026-06
Ironwood Pharmaceuticals USD 3.24M 339K 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Lexicon Pharmaceuticals USD 3M 87K 2026-03
MacroGenics USD 4.29M 500K 2026-03
Moderna USD 167M 6M 2026-06
Myriad Genetics USD 30.4M 2.2M 2026-06
Pacira USD 14.01M 1.14M 2026-03
PTC Therapeutics USD 40.45M 14.96M 2026-06
Puma Biotechnology USD 6.39M 962K 2025-09
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Takeda JPY 446.78B 44.56B 2026-06
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12